Giant mitochondria in human liver disease.

crystal-like inclusions diagnostic microscopy electron tomography fatty liver disease histopathological marker mitochondrial aberrations volume electron microscopy

Journal

Liver international : official journal of the International Association for the Study of the Liver
ISSN: 1478-3231
Titre abrégé: Liver Int
Pays: United States
ID NLM: 101160857

Informations de publication

Date de publication:
11 2023
Historique:
received: 03 07 2023
accepted: 11 08 2023
medline: 23 10 2023
pubmed: 24 8 2023
entrez: 24 8 2023
Statut: ppublish

Résumé

This thematic review aims to provide an overview of the current state of knowledge about the occurrence of giant mitochondria or megamitochondria in liver parenchymal cells. Their presence and accumulation are considered to be a major pathological hallmark of the health and fate of liver parenchymal cells that leads to overall tissue deterioration and eventually results in organ failure. The first description on giant mitochondria dates back to the 1960s, coinciding with the availability of the first generation of electron microscopes in clinical diagnostic laboratories. Detailed accounts on their ultrastructure have mostly been described in patients suffering from alcoholic liver disease, chronic hepatitis, hepatocellular carcinoma and non-alcoholic fatty liver disease. Interestingly, from this extensive literature survey, it became apparent that giant mitochondria or megamitochondria present themselves with or without highly organised crystal-like intramitochondrial inclusions. The origin, formation and potential role of giant mitochondria remain to-date largely unanswered. Likewise, the biochemical composition of the well-organised crystal-like inclusions and their possible impact on mitochondrial function is unclear. Herein, concepts about the possible mechanism of their formation and three-dimensional architecture will be approached. We will furthermore discuss their importance in diagnostics, including future research outlooks and potential therapeutic interventions to cure liver disease where giant mitochondria are implemented.

Identifiants

pubmed: 37615254
doi: 10.1111/liv.15711
doi:

Banques de données

ClinicalTrials.gov
['NCT02422238']

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

2365-2378

Informations de copyright

© 2023 The Authors. Liver International published by John Wiley & Sons Ltd.

Références

Claude A, Fullam EF. An electron microscop study of isolated mitochondria: method and preliminary results. J exp Med. 1945;81(1):51-62.
Palade GE. An electron microscope study of the mitochondrial structure. J Histochem Cytochem. 1953;1(4):188-211.
Moberg CL. Chapter 6. Cytology: the tentative beginings. In: Moberg CL, ed. Entering an unseen world. The Rockefeller University Press; 2012:111-126.
Hogeboom GH, Schneider WC, Pallade GE. Cytochemical studies of mammalian tissues; isolation of intact mitochondria from rat liver; some biochemical properties of mitochondria and submicroscopic particulate material. J Biochem. 1948;172(2):619-635.
Daems WT, Wisse E. Shape and attachment of the cristae mitochondriales in mouse hepatic cell mitochondria. J Ultrastruct Res. 1966;16(1):123-140.
Krstić RV. Mitochondrial matrix. Morphologically discrete structures. Cells of the rat and human. In: Krstić RV, ed. Ultrastructure of the Mammalian Cell: An Atlas. Springer; 1979:54-55.
Themann H, von Bassewitz DB. Parakristalline Einschußkörper der mitochondrien des menschlichen leberparenchyms. Elektronenmikroskopische Und Histochemische Untersuchungen. Cytobiologie. 1969;1:135-151.
Ekholm R, Edlund Y. The mitochondria in human normal and cholestatic liver. In: Bargmann, W., Möllenstedt, G., Niehrs, H., Peters, D., Ruska, E., Wolpers, C., eds. Fourth International Conference on Electron Microscopy (1958). Berlin: Springer-Verlag; 1960:273-275.
Novikoff AB, Essner E. The liver cell: some new approaches to its study. Am J Med. 1960;29(1):102-131.
Tandler B, Hoppel CL. Giant mitochondria (megamitochondria). In: Lennarz WJ, Lane MD, eds. Encyclopedia of Biological Chemistry. 2nd ed. Academic Press Elsevier; 2013:375-376.
Feldman M, Friedman LS, Brandt LJ. Sleisenger and Fordtran's Gastrointestinal and Liver Disease: Pathophysiology, Diagnosis, Management Vol I & II. Elsevier; 2020.
Kurtz SM, ed. Electron Microscopic Anatomy. New York: Academic Press; 1964:435.
Trump BF, Jones RT, eds. Diagnostic Electron Microscopy. Chichester: Academic Press; 1978:360.
Steiner JW, Phillips MJ, Miyai K. Ultrastructural and subcellular pathology of the liver. Int Rev exp Pathol. 1964;3:65-167.
Laschi R, Busachi CA. Electron microscopy in human liver pathology. In: Motta PM, DiDio LJA, eds. Basic and Clinical Hepatology. Developments in Gastroenterology. Vol 2. Springer; 1982:137-161.
Shapiro SH, Wessely Z, Klavins JV. Hepatocyte mitochondrial alterations in griseofulvin fed mice. Ann Clin Lab Sci. 1980;10(1):45-53.
Sternlieb I, Berger JE. Optical diffraction studies of crystalline structures in electron micrographs. II. Crystalline inclusions in mitochondria of human hepatocytes. J Cell Biol. 1969;43(3):448-455.
Stewart RV, Dincsoy HP. The significance of giant mitochondria in liver biopsies as observed by light microscopy. Am J Clin Pathol. 1982;78(3):293-298.
Rolfes DB, Ishak KG. Acute fatty liver of pregnancy: a clinicopathologic study of 35 cases. Hepatology. 1985;5(6):1149-1158.
Karbowski M, Kurono C, Wozniak M, et al. Free radical-induced megamitochondria formation and apoptosis. Free Radic Biol Med. 1999;26(3-4):396-409.
Bruguera M, Bertran A, Bombi JA, Rodes J. Giant mitochondria in hepatocytes: a diagnostic hint for alcoholic liver disease. Gastroenterology. 1977;73(6):1383-1387.
Schaffer F, Loebel A, Weiner HA, Barka T. Hepatocellular cytoplasmic changes in acute alcoholic hepatitis. JAMA. 1963;i83:343-346.
Iseri OA, Gottlieb LS. Alcoholic hyalin and megamitochondria as seperate and distinct entities in liver disease associated with alcoholism. Gastroenterology. 1971;60(6):1027-1035.
Wills EJ. Crystalline structures in the mitochondria of normal human liver parenchymal cells. J Cell Biol. 1965;24(3):511-514.
Ghadially FN, Parry EW. Ultrastructure of a human hepatocellular carcinoma and surrounding non-neoplastic liver. Cancer. 1966;19(12):1989-2004.
Zaragozá R, Renau-Piqueras J, Portolés M, Hernández-Yago J, Jordá A, Grisolía S. Rats fed prolonged high protein diets show an increase in nitrogen metabolism and liver megamitochondria. Arch Biochem Biophys. 1987;258(2):426-435.
Svoboda DJ, Manning RT. Chronic alcoholism with fatty metamorphosis of the liver. Mitochondrial alterations in hepatic cells. Am J Pathol. 1964;44(4):645-662.
Albring M, Radsak K, Thoenes W. Giant mitochondria. II. Induction of matrix enriched megamitochondria in mouse liver parenchymal cells by ethidium bromide. Virchows Arch B Cell Pathol. 1973;14(4):373-377.
Sato T, Tauchi H. The formation of enlarged and giant mitochondria in the aging process of human hepatic cells. Acta Pathol Jpn. 1975;25(4):403-412.
Feldmann G, Maurice M, Husson JM, et al. Hepatocyte giant mitochondria: an almost constant lesion in systemic scleroderma. Virchows Arch A Pathol Anat Histol. 1977;374(3):215-227.
Matsuhashi T, Liu X, Nishizawa Y, Usukura J, Wozniak M, Wakabayashi T. Mechanism of the formation of megamitochondria in the mouse liver induced by chloramphenicol. Toxicol Lett. 1996;86(1):47-54.
Kane, GC, Korula, J. Atlas of Liver Pathology. Philadelphia: Saunders, an imprint of Elsevier Inc.; 2011:523.
Hernandez-Tejero M, Clemente-Sanchez A, Bataller R. Spectrum, screening, and diagnosis of alcohol-related liver disease. J Clin exp Hepatol. 2023;13(1):75-87.
Warren M, Shimura M, Wartchow EP, Yano S. Use of electron microscopy when screening liver biopsies from neonates and infants: experience from a single tertiary children's hospital (1991-2017). Ultrastruct Pathol. 2020;44(1):32-41.
Barbaro G, Di Lorenzo G, Belloni G, Asti A, Pellicelli AM, Barbarini G. Hepatic iron storage and megamitochondria formation in patients with chronic hepatitis C related to the hepatitis C virus genotype. Dig Liver Dis. 2001;33(1):81-83.
Wakabayashi T. Megamitochondria formation - physiology and pathology. J Cell Mol Med. 2002;6(4):497-538.
Le TH, Caldwell SH, Redick JA, et al. The zonal distribution of megamitochondria with crystalline inclusions in nonalcoholic steatohepatitis. Hepatology. 2004;39(5):1423-1429.
Ando T, Bhamidimarri SP, Brending N, et al. The 2018 correlative microscopy techniques roadmap. J Phys D Appl Phys. 2018;51(44):443001.
Wolf SG, Frenkiel D, Arad T, Finkel SE, Kolter R, Minsky A. DNA protection by stress-induced biocrystallization. Nature. 1999;400(6739):83-85.
Palma E, Doornebal EJ, Chokshi S. Precision-cut liver slices: a versatile tool to advance liver research. Hepatol Int. 2019;13(1):51-57.
Verhaegh P, Wisse E, de Munck T, et al. Electron microscopic observations in perfusion-fixed human non-alcoholic fatty liver disease biopsies. Pathology. 2021;53(2):220-228.
Wisse E, Braet F, Shami GJ, et al. Fat causes necrosis and inflammation in parenchymal cells in human steatotic liver. Histochem Cell Biol. 2022;157(1):27-38.
Shami GJ, Cheng D, Verhaegh P, Koek G, Wisse E, Braet F. Three-dimensional ultrastructure of giant mitochondria in human non-alcoholic fatty liver disease. Sci Rep. 2021;11:3319.
Khairnar R, Islam MA, Fleishman J, Kumar S. Shedding light on non-alcoholic fatty liver disease: pathogenesis, molecular mechanisms, models, and emerging therapeutics. Life Sci. 2023;312:121185.
Karkucinska-Wieckowska A, Simoes ICM, Kalinowski P, et al. Mitochondria, oxidative stress and nonalcoholic fatty liver disease: a complex relationship. Eur J Clin Invest. 2022;53(3):e13622.
Longo M, Meroni M, Paolini E, Macchi C, Dongiovanni P. Mitochondrial dynamics and nonalcoholic fatty liver disease (NAFLD): new perspectives for a fairy-tale ending? Metabolism. 2021;117:154708.
Fromenty B, Roden M. Mitochondrial alterations in fatty liver diseases. J Hepatol. 2023;78(2):415-429.
Klecker T, Westermann B. Pathways shaping the mitochondrial inner membrane. Open Biol. 2021;11(12):210238.
Ma X, Chen A, Melo L, et al. Loss of hepatic DRP1 exacerbates alcoholic hepatitis by inducing megamitochondria and mitochondrial maladaptation. Hepatology. 2023;77(1):159-175.
Palma E, Ma X, Riva A, et al. Dynamin-1-like protein inhibition drives megamitochondria formation as an adaptive response in alcohol-induced hepatotoxicity. Am J Pathol. 2019;189(3):580-589.
Duranova H, Valkova V, Knazicka Z, Olexikova L, Vasicek J. Mitochondria: a worthwhile object for ultrastructural qualitative characterization and quantification of cells at physiological and pathophysiological states using conventional transmission electron microscopy. Acta Histochem. 2020;122(8):151646.
Wisse E, Braet F, Duimel H, et al. Assesment of fixation methods for the study of human and other livers by electron microscopy. World J Gastroenterol. 2010;16:2851-2866.
Vreuls C, Wisse E, Duimel H, et al. Jet-fixation: a novel method to improve microscopy of human liver needle biopsies. Hepatology. 2014;59:737-739.
Kievits AJ, Lane R, Carroll EC, Hoogenboom JP. How innovations in methodology offer new prospects for volume electron microscopy. J Microsc. 2022;287(3):114-137.
Zinchenko V, Hugger J, Uhlmann V, Arendt D, Kreshuk A. MorphoFeatures for unsupervised exploration of cell types, tissues, and organs in volume electron microscopy. Elife. 2023;12:e80918.
Eisenstein M. Seven technologies to watch in 2023. Nature. 2023;613(7945):794-797.
Shami G, Cheng D, Huynh M, Vreuls C, Wisse E, Braet F. 3-D EM exploration of the hepatic microarchitecture - lessons learned from large-volume in situ serial sectioning. Sci Rep. 2016;6:36744.
Shami GJ, Zapotoczny B, Wisse E, Braet F. Microscopic Imaging of Hepatic Sinusoidal Cells: Fifty Years in the Making. In: Gracia J, ed. Sinusoidal Cells in Liver Diseases: Role in Their Pathophysiology, Diagnosis, and Treatment. Amsterdam: Elsevier;2023.
Shami GJ, Cheng D, Braet F. Expedited large-volume 3-D SEM workflows for comparative microanatomical imaging. Methods Cell Biol. 2019;152:23-39.
Scotuzzi M, Kuipers J, Wensveen DI, et al. Multi-color electron microscopy by element-guided identification of cells, organelles and molecules. Sci Rep. 2017;7:45970.
Guo A, Zhang J, He B, et al. Quantitative, in situ visualization of intracellular insulin vesicles in pancreatic beta cells. Proc Natl Acad Sci USA. 2022;119(32):e2202695119.
Boengler K, Kosiol M, Mayr M, Schulz R, Rohrbach S. Mitochondria and ageing: role in heart, skeletal muscle and adipose tissue. J Cachexia Sarcopenia Muscle. 2017;8(3):349-369.
Legaki AI, Moustakas II, Sikorska M, Papadopoulos G, Velliou RI, Chatzigeorgiou A. Hepatocyte mitochondrial dynamics and bioenergetics in obesity-related non-alcoholic fatty liver disease. Curr Obes Rep. 2022;11(3):126-143.
Mihajlovic M, Vinken M. Mitochondria as the target of hepatotoxicity and drug-induced liver injury: molecular mechanisms and detection methods. Int J Mol Sci. 2022;23(6):3315.
Yamada Y, Satrialdi Hibino M, Sasaki D, Abe J, Harashima H. Power of mitochondrial drug delivery systems to produce innovative nanomedicines. Adv Drug Deliv Rev. 2020;154-155:187-209.
Yamada T, Murata D, Kleiner DE, et al. Prevention and regression of megamitochondria and steatosis by blocking mitochondrial fusion in the liver. iScience. 2022;25(4):103996.
Uchida T, Kronborg I, Peters RL. Giant mitochondria in the alcoholic liver diseases-their identification, frequency and pathologic significance. Liver. 1984;4(1):29-38.
Shami GJ, Cheng D, Braet F. Combined multidimensional microscopy as a histopathology imaging tool. J Cell Physiol. 2017;322(2):249-256.
Liu L, Yang S, Liu Y, et al. DeepContact: high-throughput quantification of membrane contact sites based on electron microscopy imaging. J Cell Biol. 2022;221(9):e202106190.

Auteurs

Gerald J Shami (GJ)

School of Medical Sciences (Molecular and Cellular Biomedicine), The University of Sydney, Sydney, New South Wales, Australia.
Australian Centre for Microscopy and Microanalysis, The University of Sydney, Sydney, New South Wales, Australia.

Iryna V Samarska (IV)

Pathology, Maastricht University Medical Center, Maastricht, The Netherlands.

Ger H Koek (GH)

Department of Internal Medicine division of Gastroenterology & Hepatology, Maastricht University Medical Center, Maastricht, The Netherlands.

Amy Li (A)

Centre for Healthy Futures, Torrens University Australia, Sydney, New South Wales, Australia.
Department of Pharmacy & Biomedical Sciences, La Trobe University, Melbourne, Victoria, Australia.

Elena Palma (E)

The Roger Williams Institute of Hepatology, Foundation for Liver Research, London, UK.
King's College London, Faculty of Life Sciences and Medicine, London, UK.

Shilpa Chokshi (S)

King's College London, Faculty of Life Sciences and Medicine, London, UK.

Eddie Wisse (E)

Division of Nanoscopy, Multimodal Molecular Imaging Institute, University of Maastricht, Maastricht, The Netherlands.

Filip Braet (F)

School of Medical Sciences (Molecular and Cellular Biomedicine), The University of Sydney, Sydney, New South Wales, Australia.
Australian Centre for Microscopy and Microanalysis, The University of Sydney, Sydney, New South Wales, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH